ClinicalTrials.gg
Sign In

Mesothelioma, Malignant clinical trials

The registry lists 339 studies for Mesothelioma, Malignant across more than 10 countries. 64 are recruiting or about to start. 247 of them are mainly about Mesothelioma, Malignant (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Mesothelioma, Malignant studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
161
Recruiting
55
Terminated
41
Status unknown
33
Active, not recruiting
23
Withdrawn
14

Phase

Phase 2
171
Phase 1
127
Phase 3
18
Early Phase 1
2
Phase 4
1

Where

United States
164
Italy
45
United Kingdom
41
France
29
Netherlands
22
China
20

Who runs them

National Cancer Institute (NCI) (33) · Memorial Sloan Kettering Cancer Center (15) · M.D. Anderson Cancer Center (9) · Alliance for Clinical Trials in Oncology (7) · European Organisation for Research and Treatment of Cancer - EORTC (7) · Ain Shams University (6) · Abramson Cancer Center at Penn Medicine (5) · University of Chicago (5)

What is being tested here

Drugs under test in Mesothelioma, Malignant studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Nivolumab208
Atezolizumab217
Ivonescimab203
Interleukin-2203
Cadonilimab202
Cisplatin1227
Pemetrexed1218
Pembrolizumab106
Carboplatin104
Decitabine104

Drug classes tested here Immune checkpoint inhibitors 14 open · Tyrosine kinase inhibitors (TKIs) 3 open · Antimetabolites 2 open · PARP inhibitors 1 open · Angiogenesis inhibitors 6

Coming up

3phase 3 studies under way
19studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 55 Mesothelioma, Malignant studies recruiting now, 43 (78%) set no upper age limit and 5 (9%) stop at 75 or younger. 2 (4%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 3 (5%) take healthy volunteers.

Recruiting studies that take each age, of 55
AgeWomenMen
102 (4%)2 (4%)
1854 (98%)54 (98%)
3055 (100%)55 (100%)
4055 (100%)55 (100%)
5055 (100%)55 (100%)
6555 (100%)55 (100%)
7554 (98%)54 (98%)
8548 (87%)48 (87%)

Across all 339 studies, recruiting or not: 8% stop at 75 or younger and 2% at 65; 8% take children; 1% are for women only and <1% for men only; 2% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Mesothelioma, Malignant studies take

Of 48 phase 2 interventional studies under Mesothelioma, Malignant, half reached primary completion within 48 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 163 mo39–89 · 40 studies——
Phase 1/267 mo43–85 · 30 studies——
Phase 248 mo29–87 · 48 studies—67 mo27–100 · 41 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting1

Stopped1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 339. Browse all 339 → or search them.